The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00393653
(Funding ended early)
The purpose of this study is to evaluate whether a novel prescription method (N-of-1 intervention)can be successfully integrated into primary care practices and to examine the effects of this prescription method on selected patient health outcomes (e.g.., medication compliance, medication costs, symptom management, satisfaction of physician/patient visit, etc.) in patients with a uncontrolled or new diagnosis of Osteoarthritis or Chronic Heartburn (GERD).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
at least 18 years old
capable of giving informed consent
a new diagnosis or uncontrolled symptoms of either osteoarthritis or gastroesophageal reflux disease
if new diagnosis or uncontrolled osteoarthritis, patient must have condition in knee or hip (need not be isolated)
too ill to participate
not capable of giving informed consent
not able to be contacted via phone for study follow-up
unable to read English, including blindness
if treating physician considers patient to have medical conditions that would cause the patient to be placed at risk by trial participation